BOSTON (Reuters) – Hedge fund Sachem Head Capital Management has built a $1.2 billion stake in Elanco Animal Health Inc (N:) and plans to push for changes at the company that makes medicines and vaccinations for pets and livestock, a person familiar with the matter said on Wednesday.
The investment, first reported by Bloomberg, translates into a stake of 9.1% in Elanco which is valued at $14 billion.
Elanco’s stock price climbed as much as 9% on news that Sachem Head, run by Scott Ferguson, plans engage with management to push for improvements.
Ferguson raised cash for the position through a so-called special purpose vehicle over the last months and has experience in investing in animal health after making a bet on Zoetis (N:) in 2014.
Elanco and Zoetis are competitors but Elanco has lagged with its shares up only 5.4% from a year ago, while Zoetis’ stock has climbed 27% during the same time.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.